Publication Name	World Journal of Gastroenterology
Manuscript ID	6858
Country	China

Received	2013-10-29 15:52
Peer-Review Started	2013-10-30 20:06
To Make the First Decision	2013-12-04 08:48
Return for Revision	2013-12-04 19:44
Revised
Second Decision	2014-03-19 13:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-03-19 15:01
Articles in Press	2014-05-23 11:29
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-06-06 15:04
Publish the Manuscript Online	2014-06-27 10:37

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Emerging antivirals for the treatment of hepatitis B
Manuscript Source	Invited Manuscript
All Author List	Xue-Yan Wang and Hong-Song Chen
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 31340023 National Natural Science Foundation of China 91029741 National Natural Science Foundation of China 81001072 National Natural Science Foundation of China 81171550 National Key Sci-Tech Special Project of China 2012ZX10002011-006 Doctoral Program of Higher Education 20130001120075 Peking University People’s Hospital Research and Development Funds RDB2013-02
Corresponding Author	Hong-Song Chen, MD, PhD, Professor, Peking University Hepatology Institute, Peking University People’s Hospital, Xizhimen South Road 11, Beijing 100044, China. chenhongsong@pkuph.edu.cn
Key Words	Hepatitis B; Antiviral; Nucleoside analogue; Nucleotide analogue; Non-nucleoside antivirals
Core Tip	Despite the presence of an effective vaccine, chronic infection with hepatitis B virus remains a global public health problem. This review summary the emerging antivirals directed at novel targets derived from mechanisms of viral cellular entry, viral replication, viral assembly, and the host immune response, leading to preclinical and clinical trials for possible future therapeutic intervention.
Publish Date	2014-06-27 10:37
Citation	Wang XY, Chen HS. Emerging antivirals for the treatment of hepatitis B. World J Gastroenterol 2014; 20(24): 7707-7717
URL	http://www.wjgnet.com/1007-9327/full/v20/i24/7707.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i24.7707

Full Article (PDF)	WJG-20-7707.pdf
Full Article (Word)	WJG-20-7707.doc
Manuscript File	6858-Review.docx
Answering Reviewers	6858-Answering reviewers.pdf
Copyright License Agreement	6858-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	6858-Language certificate.pdf
Peer-review Report	6858-Peer review(s).pdf
Scientific Editor Work List	6858-Scientific editor work list.doc